4

$AMGN · Amgen Inc.

November 9, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Amgen director Omar Ishrak filed a Form 4 reporting a change in beneficial ownership on November 6, 2026. He acquired 152.0351 shares of Amgen common stock at a price of $0, bringing his total direct holdings to 7,681.9397 shares. The acquisition was reported as a grant of shares rather than an open-market purchase.

The filing explains that the acquired shares include 504 dividend equivalents credited to unvested restricted stock units under the company’s equity incentive plan. These dividend equivalents are paid out in common stock on a one-to-one basis according to the vesting schedule, with any fractional share amount paid in cash. The underlying restricted stock units were granted under the Amgen Inc. 2009 Director Equity Incentive Program and vested immediately. Vested units are paid in common stock on a one-to-one basis, though a director may elect to defer payment according to a chosen schedule.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →